TrialCancer immunology, immunotherapy : CII2019

Phase I/II clinical trial of a Wilms' tumor 1-targeted dendritic cell vaccination-based immunotherapy in patients with advanced cancer.

Wen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.